(Q37932072)

25 August 2017

1 reference

title

Leptin for type 1 diabetes: coming onto stage to be (or not?). (English)

1 reference

25 August 2017

0 references

Elif A Oral

1

1 reference

25 August 2017

14 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

13

1 reference

25 August 2017

1

1 reference

25 August 2017

68-73

1 reference

Leptin therapy in insulin-deficient type I diabetes

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Leptin and the regulation of body weight in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Selective deletion of leptin receptor in neurons leads to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Recombinant human leptin in women with hypothalamic amenorrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

The physiology of cellular liporegulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Rationale for leptin-replacement therapy for severe lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5448.2011.00797.X

10.1111/J.1399-5448.2011.00797.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21917108